Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eikon Therapeutics
Rutgers, The State University of New Jersey
M.D. Anderson Cancer Center
GI Innovation, Inc.
Eli Lilly and Company
PMV Pharmaceuticals, Inc
Mayo Clinic
Ascendis Pharma A/S
Tizona Therapeutics, Inc
Essen Biotech
Sairopa B.V.
NuCana plc
Medicenna Therapeutics, Inc.
M.D. Anderson Cancer Center
Carisma Therapeutics Inc
NextCure, Inc.
Salubris Biotherapeutics Inc
Pliant Therapeutics, Inc.
Eli Lilly and Company
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Incyte Corporation